172 related articles for article (PubMed ID: 22022805)
1. Pharmacological characterization of GSK1004723, a novel, long-acting antagonist at histamine H(1) and H(3) receptors.
Slack RJ; Russell LJ; Hall DA; Luttmann MA; Ford AJ; Saunders KA; Hodgson ST; Connor HE; Browning C; Clark KL
Br J Pharmacol; 2011 Nov; 164(6):1627-41. PubMed ID: 22022805
[TBL] [Abstract][Full Text] [Related]
2. In vitro characterisation of the duration of action of the histamine-1 receptor antagonist azelastine.
Slack RJ; Hart AD; Luttmann MA; Clark KL; Begg M
Eur J Pharmacol; 2011 Nov; 670(2-3):586-92. PubMed ID: 21946109
[TBL] [Abstract][Full Text] [Related]
3. A role for histamine and substance P in immediate allergic responses in guinea pig airways: characterization of MDL 108,207DA, a dual H1/NK-1 receptor antagonist.
Kudlacz E; Shatzer S; Logan D; Olsen K; Knippenberg R; Hsieh L; Esteve H; Maynard G
Int Arch Allergy Immunol; 1998 Feb; 115(2):169-78. PubMed ID: 9482707
[TBL] [Abstract][Full Text] [Related]
4. The discovery of quinoline based single-ligand human H
Procopiou PA; Ancliff RA; Gore PM; Hancock AP; Hodgson ST; Holmes DS; Keeling SP; Looker BE; Parr NA; Rowedder JE; Slack RJ
Bioorg Med Chem Lett; 2016 Dec; 26(24):5855-5859. PubMed ID: 27866818
[TBL] [Abstract][Full Text] [Related]
5. The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.
Procopiou PA; Browning C; Buckley JM; Clark KL; Fechner L; Gore PM; Hancock AP; Hodgson ST; Holmes DS; Kranz M; Looker BE; Morriss KM; Parton DL; Russell LJ; Slack RJ; Sollis SL; Vile S; Watts CJ
J Med Chem; 2011 Apr; 54(7):2183-95. PubMed ID: 21381763
[TBL] [Abstract][Full Text] [Related]
6. Preclinical pharmacology of bilastine, a new selective histamine H1 receptor antagonist: receptor selectivity and in vitro antihistaminic activity.
Corcóstegui R; Labeaga L; Innerárity A; Berisa A; Orjales A
Drugs R D; 2005; 6(6):371-84. PubMed ID: 16274260
[TBL] [Abstract][Full Text] [Related]
7. Preclinical efficacy and safety pharmacology of SUN-1334H, a potent orally active antihistamine agent.
Mandhane SN; Ayer UB; Midha AS; Rao CT; Rajamannar T
Drugs R D; 2008; 9(2):93-112. PubMed ID: 18298128
[TBL] [Abstract][Full Text] [Related]
8. Elevated nasal mucosal G protein levels and histamine receptor affinity in a guinea pig model of nasal hyperresponsiveness.
Chiba Y; Saitoh N; Matsuo K; Misawa M
Int Arch Allergy Immunol; 2002 Apr; 127(4):285-93. PubMed ID: 12021547
[TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and tolerability of two novel H(1)/H(3) receptor antagonists in seasonal allergic rhinitis.
Daley-Yates P; Ambery C; Sweeney L; Watson J; Oliver A; McQuade B
Int Arch Allergy Immunol; 2012; 158(1):84-98. PubMed ID: 22212854
[TBL] [Abstract][Full Text] [Related]
11. Bronchodilator activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a potent, long-acting, and selective muscarinic M3 receptor antagonist.
Villetti G; Pastore F; Bergamaschi M; Bassani F; Bolzoni PT; Battipaglia L; Amari G; Rizzi A; Delcanale M; Volta R; Cenacchi V; Cacciani F; Zaniboni M; Berti F; Rossoni G; Harrison S; Petrillo P; Santoro E; Scudellaro R; Mannini F; Geppetti PA; Razzetti R; Patacchini R; Civelli M
J Pharmacol Exp Ther; 2010 Dec; 335(3):622-35. PubMed ID: 20805306
[TBL] [Abstract][Full Text] [Related]
12. New H1/H3 antagonists for treating allergic rhinitis: WO2010094643.
Norman P
Expert Opin Ther Pat; 2011 Mar; 21(3):425-9. PubMed ID: 21342057
[TBL] [Abstract][Full Text] [Related]
13. Neurokinin A-LI release after antigen challenge in guinea-pig bronchial tubes: influence of histamine and bradykinin.
Lindström EG; Andersson RG
Br J Pharmacol; 1997 Oct; 122(3):417-22. PubMed ID: 9351496
[TBL] [Abstract][Full Text] [Related]
14. Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.
Mikó T; Ligneau X; Pertz HH; Ganellin CR; Arrang JM; Schwartz JC; Schunack W; Stark H
J Med Chem; 2003 Apr; 46(8):1523-30. PubMed ID: 12672253
[TBL] [Abstract][Full Text] [Related]
15. A novel fluorescent histamine H(1) receptor antagonist demonstrates the advantage of using fluorescence correlation spectroscopy to study the binding of lipophilic ligands.
Rose RH; Briddon SJ; Hill SJ
Br J Pharmacol; 2012 Mar; 165(6):1789-1800. PubMed ID: 21880035
[TBL] [Abstract][Full Text] [Related]
16. Effect of combined histamine H1 and H3 receptor blockade on cutaneous microvascular permeability elicited by compound 48/80.
McLeod RL; Mingo GG; Kreutner W; Hey JA
Life Sci; 2005 Mar; 76(16):1787-94. PubMed ID: 15698856
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characterization of desloratadine, a potent antagonist of the human histamine H(1) receptor.
Anthes JC; Gilchrest H; Richard C; Eckel S; Hesk D; West RE; Williams SM; Greenfeder S; Billah M; Kreutner W; Egan RE
Eur J Pharmacol; 2002 Aug; 449(3):229-37. PubMed ID: 12167464
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of [3H]-pyrilamine binding and of the histamine-induced inositol phosphates generation, intracellular Ca2+ -mobilization and cytokine release from human corneal epithelial cells.
Sharif NA; Wiernas TK; Griffin BW; Davis TL
Br J Pharmacol; 1998 Nov; 125(6):1336-44. PubMed ID: 9863665
[TBL] [Abstract][Full Text] [Related]
19. Emedastine: a potent, high affinity histamine H1-receptor-selective antagonist for ocular use: receptor binding and second messenger studies.
Sharif NA; Su SX; Yanni JM
J Ocul Pharmacol; 1994; 10(4):653-64. PubMed ID: 7714409
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of new thioperamide derivatives at histamine peripheral H1-, H2-, H3-receptors in guinea-pig.
Barocelli E; Ballabeni V; Caretta A; Bordi F; Silva C; Morini G; Impicciatore M
Agents Actions; 1993 Mar; 38(3-4):158-64. PubMed ID: 8213342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
